TheraRadar
← Back
Data updated: Mar 29, 2026

EVUS

CardiovascularInfectious DiseaseDermatology
Pharma

EVUS is a pharmaceutical company focused on Cardiovascular, Infectious Disease, Dermatology.

2006
Since
1
Drugs
-
Trials
0
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

No recent activity
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 38%
1 drugs
Infectious Disease 38%
0 drugs Phase 3: 1 Phase 2: 1
Dermatology 25%
0 drugs Phase 3: 1

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...